Loading clinical trials...
Loading clinical trials...
Sars-Cov2 Antibodies Response to vaccinE Against covId-19 Disease
Conditions
Interventions
BNT162b2 mRNA Covid-19 Vaccine
Locations
1
Italy
ICOT-Sapienza University Hospital
Latina, LT, Italy
Start Date
January 28, 2021
Primary Completion Date
July 31, 2021
Completion Date
February 1, 2022
Last Updated
May 11, 2021
NCT07221162
NCT06082518
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
University of Roma La Sapienza
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions